Join The Advisor Team
More

Tag: commercialization strategy

James Kappas: Driving Innovation in Food and Beverage Ingredients; “Being Genuine and Realistic in Every Step of the Journey.”

I’m excited to share my executive biography, highlighting my journey in the food and beverage industry, my passion for ingredient innovation, and my strategic leadership in commercializing new technologies. With 40+ years of experience across global markets, I look forward to continuing to drive growth and innovation in the sector.

William T. Beane: “Innovating Beyond Boundaries: Bridging Technology, Strategy, and Market Success.”

I am excited to share my executive biography, which highlights my journey through technology innovation, business strategy, and leadership development. With over 35 years of experience in product development, commercialization, and global market expansion, I remain passionate about driving impactful change and fostering high-performance teams. If you are looking for an experienced executive to contribute to strategic growth and innovation, I’d love to connect.

Michael Eckstut – Senior Life Sciences Executive and Strategic Advisor

Michael Ekstut is a seasoned business leader with over 30 years of experience in the life sciences industry, specializing in drug discovery, development, and regulatory strategy. He has held senior leadership roles at industry-leading companies, including Certara, where he guided the company’s commercial and product strategy in the regulatory and access sector. Michael is known for his strategic vision and ability to drive innovation, optimizing clinical development programs and supporting biopharma companies in navigating complex regulatory landscapes. His deep expertise in business consulting, technology, and operational management has enabled him to successfully advise executives and investors across pharmaceuticals, biotechnology, and medical devices. Currently serving as a Senior Advisor at InSilicoTrials, Michael continues to leverage his vast experience to help organizations maximize the impact of their clinical development programs and investments.